BRAF gene is not mutated in plasma cell leukemia and multiple myeloma [4]

Leukemia

Volumn 17, Issue 11, 2003, Pages 2238-2240

  Bonello, L ^a   Voena, C ^a   Ladetto, M ^a   Boccadoro, M ^a   Palestro, G ^a   Inghirami, G ^a   Chiarle, R ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE;

AMINO ACID SUBSTITUTION; BONE MARROW BIOPSY; CANCER GROWTH; CARCINOGENESIS; DIAGNOSTIC ACCURACY; ENZYME ACTIVATION; EXON; GENE MUTATION; HUMAN; LETTER; LEUKEMIA CELL; LEUKEMOGENESIS; MELANOMA CELL; MULTIPLE MYELOMA; MUTATIONAL ANALYSIS; NUCLEIC ACID BASE SUBSTITUTION; ONCOGENE K RAS; ONCOGENE N RAS; PLASMA CELL LEUKEMIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS;

EID: 0242391862     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403116     Document Type: Letter

References (8)

1. Boettner B, Van Aelst L. The RASputin effect. Genes Dev 2002; 16: 2033-2038.
2. Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interaction. Biochem J 2000; 351: 289-305.
3. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949-954.
4. Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE. RAF/RAS oncogenes and mismatch-repair status. Nature 2002; 418: 934.
5. Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM et al. High frequency of BRAF mutations in nevi. Nat Genet 2003; 33: 19-20.
6. Corradini P, Ladetto M, Voena C, Palumbo A, Inghirami G, Knowles DM et al. Mutational activation of N- and K-ras oncogene in plasma cell dyscrasias. Blood 1993; 81: 2708-2713.
7. Bezieau S, Avet-Loiseau H, Moisan JP, Bataille R. Activating Ras mutations in patients with plasma-cell disorders: a reappraisal. Blood 2002; 100: 1101-1104.
8. Smith ML, Snaddon J, Neat M, Cambal-Parrales M, Arch R, Lister TA et al. Mutation of BRAF is uncommon in AML FAB type M1 and M2. Leukemia 2003; 17: 274-275.